NCT07511972 Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies Status WITHDRAWN Phase PHASE2
NCT07397338 Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT07381309 Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM Status NOT_YET_RECRUITING Phase PHASE2
NCT07349537 Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors Status RECRUITING Phase PHASE1
NCT07321106 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer Status RECRUITING Phase PHASE1
NCT07283367 A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients. Status RECRUITING Phase PHASE1/PHASE2
NCT07204574 The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06728072 Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06682793 A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06657222 First in Human Study of TUB-030 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06593548 Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06455254 Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM Status RECRUITING Phase PHASE2
NCT06445062 Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06259552 A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors Status RECRUITING Phase PHASE1
NCT06195670 Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06106308 Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06051695 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2